{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:06:40Z","timestamp":1788264400853,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.lfs.2022.120777","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T19:19:30Z","timestamp":1656789570000},"page":"120777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism"],"prefix":"10.1016","volume":"305","author":[{"given":"Paulina","family":"Koczurkiewicz-Adamczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"G\u0105siorkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Piska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Gunia-Krzy\u017cak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Jamrozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"S\u0142oczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Bojdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"W\u00f3jcik-Pszczo\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedykt","family":"W\u0142adyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Ko\u0142aczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"P\u0119kala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.120777_bb0005","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cmdc.202000131","article-title":"Antitumour anthracyclines: progress and perspectives","volume":"15","author":"Martins-Teixeira","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.lfs.2022.120777_bb0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2471\/BLT.15.163998","article-title":"Essential medicines for cancer: WHO recommendations and national priorities","volume":"94","author":"Robertson","year":"2016","journal-title":"Bull. World Health Organ."},{"issue":"3","key":"10.1016\/j.lfs.2022.120777_bb0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00109-016-1494-0","article-title":"Doxorubicin-induced chronic dilated cardiomyopathy-the apoptosis hypothesis revisited","volume":"95","author":"Kankeu","year":"2017","journal-title":"J. Mol. Med. (Berl)."},{"issue":"284","key":"10.1016\/j.lfs.2022.120777_bb0020","first-page":"1","article-title":"Doxorubicin induces wide-spread transcriptional changes in the myocardium of hearts distinguishing between mice with preserved and impaired cardiac function","volume":"1","author":"Stamm","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2022.120777_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111708","article-title":"Doxorubicin-induced cardiotoxicity: an update on the molecular mechanism and novel therapeutic strategies for effective management","volume":"139","author":"Rawat","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2022.120777_bb0030","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/03602530802431439","article-title":"The Aldo-keto reductase superfamily and its role in drug metabolism and detoxification","volume":"40","author":"Barski","year":"2008","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.lfs.2022.120777_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-12-381","article-title":"Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization","volume":"12","author":"Heibein","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2022.120777_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10637-017-0443-2","article-title":"Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents","volume":"35","author":"Piska","year":"2017","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.lfs.2022.120777_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.cbi.2019.01.003","article-title":"Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells - the involvement of carbonyl reductase 1 inhibition","volume":"300","author":"Piska","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2022.120777_bb0050","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11095-008-9592-5","article-title":"Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)","volume":"25","author":"Gonzalez-Covarrubias","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.lfs.2022.120777_bb0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cbi.2014.12.019","article-title":"Curcumin is a tight-binding inhibitor of the most efficient human daunorubicin reductase\u2013Carbonyl reductase 1","volume":"234","author":"Hintzpeter","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2022.120777_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.23723","article-title":"Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2022.120777_bb0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/0960327114527628","article-title":"Cardioprotective effects of curcumin and nebivolol against doxorubicin-induced cardiac toxicity in rats","volume":"33","author":"Imbaby","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.lfs.2022.120777_bb0070","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2018.06.057","article-title":"Piperlongumine (piplartine) as a lead compound for anticancer agents - synthesis and properties of analogues: a mini-review","volume":"156","author":"Piska","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2022.120777_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21165712","article-title":"Cinnamic acid derivatives and their biological efficacy","volume":"21","author":"Ruwizhi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.lfs.2022.120777_bb0080","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.3390\/ijms22126217","article-title":"Cinnamic acid derivatives as cardioprotective agents against oxidative and structural damage induced by doxorubicin","author":"Koczurkiewicz-Adamczyk","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.lfs.2022.120777_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105511","article-title":"Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells - involvement of carbonyl reductase 1","volume":"154","author":"Koczurkiewicz-Adamczyk","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2022.120777_bb0090","series-title":"Novel Halo-substituted Cinnamic Acid Heterocyclic Amides, US3590041","author":"Kleemann","year":"1971"},{"issue":"5","key":"10.1016\/j.lfs.2022.120777_bb0095","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41429-018-0027-1","article-title":"Anti-helicobacter pylori activities of selected N-substituted cinnamamide derivatives evaluated on reference and clinical bacterial strains","volume":"71","author":"Klesiewicz","year":"2018","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.lfs.2022.120777_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jep.2014.06.019","article-title":"Evaluation of toxicity of Calophyllum brasiliense stem bark extract by in vivo and in vitro assays","volume":"155","author":"Oliveira","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2022.120777_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jep.2017.09.027","article-title":"Evaluation of genotoxicity and subchronic toxicity of the standardized leaves infusion extract of Copaifera malmei Harms in experimental models","volume":"211","author":"Pavan","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.lfs.2022.120777_bb0110","first-page":"70","article-title":"In vitro micronucleus test assessment of polycyclic aromatic hydrocarbons","volume":"7","author":"\u017belazna","year":"2011","journal-title":"Environ. Biotechnol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120777_bb0115","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bmc.2016.11.014","article-title":"Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-cl, 4-CH3 or 2-CH3","volume":"25","author":"Gunia-Krzy\u017cak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2022.120777_bb0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.fitote.2014.12.010","article-title":"Structure-activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1)","volume":"101","author":"Arai","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.lfs.2022.120777_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol rev 56(2), 185\u2013229","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2022.120777_bb0130","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/pharmrev.120.000122","article-title":"Aldo-keto reductases and cancer drug resistance","volume":"73","author":"Penning","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.lfs.2022.120777_bb0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/dmd.119.089326","article-title":"Carbonyl reductase 1 plays a significant role in converting doxorubicin to cardiotoxic doxorubicinol in mouse liver, but the majority of the doxorubicinol-forming activity remains unidentified","volume":"48","author":"Breysse","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.lfs.2022.120777_bb0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/ars.2015.6457","article-title":"Inhibition of carbonyl reductase 1 safely improves the efficacy of doxorubicin in breast cancer treatment","volume":"26","author":"Jo","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.lfs.2022.120777_bb0145","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.biopha.2018.03.089","article-title":"P-coumaric acid mediated protection of H9c2 cells from doxorubicin-induced cardiotoxicity: involvement of augmented Nrf2 and autophagy","volume":"102","author":"Sunitha","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"107","key":"10.1016\/j.lfs.2022.120777_bb0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejmech.2015.11.003","article-title":"Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives","volume":"1","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"16","key":"10.1016\/j.lfs.2022.120777_bb0155","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.3390\/molecules26164724","article-title":"Design, synthesis and anticancer evaluation of substituted cinnamic acid bearing 2-quinolone hybrid derivatives","volume":"4","author":"Abu Almaaty","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.lfs.2022.120777_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13065-018-0411-8","article-title":"Targeting matrix metalloproteinases with novel diazepine substituted cinnamic acid derivatives: design, synthesis, in vitro and in silico studies","volume":"12","author":"Rathee","year":"2018","journal-title":"Chem Cent J."},{"key":"10.1016\/j.lfs.2022.120777_bb0165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cbi.2019.02.031","article-title":"Potent inhibition of human carbonyl reductase 1 (CBR1) by the prenylated chalconoid xanthohumol and its related prenylflavonoids isoxanthohumol and 8-prenylnaringenin","volume":"305","author":"Seliger","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2022.120777_bb0170","doi-asserted-by":"crossref","first-page":"75269","DOI":"10.21037\/cdt-19-707","article-title":"Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K\/Akt\/mTOR-dependent manner","volume":"10","author":"Yu","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.lfs.2022.120777_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114813","article-title":"Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells","volume":"193","author":"Zhou","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120777_bb0180","first-page":"4599","article-title":"Salidroside mediates apoptosis and autophagy inhibition in concanavalin A-induced liver injury","volume":"15","author":"Feng","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.lfs.2022.120777_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114188","article-title":"Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT\/mTOR signaling","volume":"180","author":"Zhang","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"328","key":"10.1016\/j.lfs.2022.120777_bb0190","article-title":"BAY60-2770 attenuates doxorubicin-induced cardiotoxicity by decreased oxidative stress and enhanced autophagy","volume":"1","author":"Zhao","year":"2020","journal-title":"Chem. Bio. Interact."},{"key":"10.1016\/j.lfs.2022.120777_bb0195","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/neuonc\/nou088","article-title":"Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells","volume":"16","author":"Kim","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"9","key":"10.1016\/j.lfs.2022.120777_bb0200","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1248\/bpb.b15-00176","article-title":"Up-regulation of carbonyl reductase 1 renders development of doxorubicin resistance in human gastrointestinal cancers","volume":"38","author":"Matsunaga","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.lfs.2022.120777_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.pharmtox.47.120505.105316","article-title":"Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology","volume":"47","author":"Oppermann","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120777_bb0210","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7150\/jca.34303","article-title":"Inhibition of carbonyl reductase 1 enhances metastasis of head and neck squamous cell carcinoma through \u03b2-catenin-mediated epithelial-mesenchymal transition","volume":"11","author":"Yun","year":"2020","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2022.120777_bb0215","first-page":"1503","article-title":"Overexpression of carbonyl reductase 1 inhibits malignant behaviors and epithelial mesenchymal transition by suppressing TGF-\u03b2 signaling in uterine leiomyosarcoma cells","volume":"18","author":"Kajimura","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2022.120777_bb0220","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/sj.bjc.6603994","article-title":"The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study","volume":"97","author":"Bruynzeel","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.lfs.2022.120777_bb0225","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1111\/bph.12995","article-title":"Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism","volume":"172","author":"Zhou","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2022.120777_bb0230","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Banks JA","year":"2004","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2022.120777_bb0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2478\/acph-2018-0021","article-title":"Insights into the mechanism of antiproliferative effects of primaquine-cinnamic acid conjugates on MCF-7 cells","volume":"68","author":"Mabeta","year":"2018","journal-title":"Acta Pharm."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522004775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522004775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:02:36Z","timestamp":1758402156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522004775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":47,"alternative-id":["S0024320522004775"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120777","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"120777"}}